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Abstract 
 
 
Active transport systems provide essential functions in terms of cell physiology and 
metastasis. These systems, however, are also co-opted by invading viruses, enabling 
directed transport of the virus to and from the cell’s nucleus (i.e., the site of virus 
replication). Based on this concept, fundamentally new approaches for interrogating and 
manipulating the inner workings of living cells may be achievable by co-opting Nature’s 
active transport systems as an in vivo biomolecular tool. The overall goal of this project 
was to investigate the ability to engineer kinesin-based transport systems for in vivo 
applications, specifically the collection of effector proteins (e.g., transcriptional 
regulators) within single cells. In the first part of this project, a chimeric fusion protein 
consisting of kinesin and a single chain variable fragment (scFv) of an antibody was 
successfully produced through a recombinant expression system. The kinesin-scFv 
retained both catalytic and antigenic functionality, enabling selective capture and 
transport of target antigens. The incorporation of a rabbit IgG-specific scFv into the 
kinesin established a generalized system for functionalizing kinesin with a wide range of 
target-selective antibodies raised in rabbits. The second objective was to develop methods 
of isolating the intact microtubule network from live cells as a platform for evaluating 
kinesin-based transport within the cytoskeletal architecture of a cell. Successful isolation 
of intact microtubule networks from two distinct cell types was demonstrated using 
glutaraldehyde and methanol fixation methods. This work provides a platform for 
inferring the ability of kinesin-scFv to function in vivo, and may also serve as a three-
dimensional scaffold for evaluating and exploiting kinesin-based transport for 
nanotechnological applications. Overall, the technology developed in this project 
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represents a first-step in engineering active transport system for in vivo applications. 
Further development could potentially enable selective capture of intracellular antigens, 
targeted delivery of therapeutic agents, or disruption of the transport systems and 
consequently the infection and pathogenesis cycle of biothreat agents. 
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1.0 Introduction 
 
Active transport systems have evolved as Nature’s means of alleviating diffusional 
constraints, specifically with relation to moving large macromolecules within the gel-like 
environment of the cytoplasm [1]. For example, diffusion of a 30-nm vesicle to a location 
3-µm away in the cytoplasm would require ~540 seconds. Alternatively, active transport 
of this vesicle across the same distance occurs in less than 5 seconds, a two-order of 
magnitude difference. Active transport systems are composed of filament networks that 
serve as tracks on which motor proteins drive the directed transport of cargo through the 
efficient conversion of chemical energy into mechanical work. These systems are 
ubiquitous in living organisms, and are fundamental to a wide range of physiological 
process including cell division, chromosome segregation, vesicle trafficking, and muscle 
actuation [2-6]. 
The cytoskeleton provides structural integrity to the cell, but also functions an 
intricate, three-dimensional network for active transport systems. Cytoskeletal filaments 
are classified into three distinct types: (i.) actin filaments, (ii.) intermediate filaments, and 
(iii.) microtubule filaments. Actin and microtubule filaments serve primarily as 
“molecular tracks” within the cell, while intermediate filaments function only as 
structural elements that reinforce the cell and help organize cells into tissues [4]. Motor 
proteins responsible for moving macromolecules along actin and microtubule filaments 
are also sub-divided into three types: myosin, kinesin, and dynein. The myosin family of 
motor proteins works in conjunction with actin filaments to facilitate contraction of 
muscle cells, as well as transport intracellular vesicles [5, 7]. Dynein and kinesin motor 
proteins are involved in bi-directional trafficking of macromolecular cargo on 
microtubule filaments [3, 7]. Dynein and kinesin are responsible for a wide array of 
functions including vesicle transport [8-10], the color changing mechanisms common in 
fish [11-13], cilia actuation [14], mitotic spindle assembly [15, 16], and lipid tubule 
formation in the endoplasmic reticulum [17]. 
The kinesin family of motor proteins contains fourteen sub-families in which distinct 
structural features and physiological roles may be assigned. Of these sub-families, 
Kinesin-1, often referred to as conventional kinesin, has been the most intensely studied. 
Conventional kinesins are homo-dimer proteins that possess three structural domains: a 
motor domain, a neck-linker region, and an α-helical, coiled-coil tail region [1-3, 7]. The 
biochemical and biophysical properties of conventional kinesin have been well-
characterized. Conventional kinesin moves processively (i.e., repetitively stepping 
without dissociating from the microtubule) from the minus-end to the plus-end of the 
microtubule filament through an asymmetric hand-over-hand mechanism [18-21]. Each 
8-nm step requires the hydrolysis of a single ATP molecule, and produces ~40 pN·nm 
mechanical work with an overall catalytic efficiency of ~50% [20-24]. As a whole, 
kinesin motor proteins represent a class of biological molecular motors crucial to the 
intracellular transport of macromolecules within the nanofluidic environment of a cell. 
The potential application of kinesin-based transport in nanoscale systems was 
recognized over 7 years ago [25], and has driven multi-disciplinary efforts focused on  
integrating these molecular motors as nanoscale actuators in hybrid systems [26-30]. 
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Reconstitution of the kinesin-microtubules in synthetic systems can be achieved in two 
different geometries [28, 30]. In the first geometry, microtubule filaments are bound to a 
positively charged surface (e.g., amine-terminated self-assembled monolayer), and serve 
as the tracks for kinesin movement; this geometry directly mimics the natural system. 
The second geometry involves the formation of a kinesin monolayer with the motor 
domains extending into the solution, and the collective movement of microtubules across 
a surface; this geometry is known as the gliding or inverted geometry. The majority of 
work in applying kinesin and microtubules to nanoscale systems has focused on the 
gliding motility geometry as a “molecular shuttle” for moving nanoparticles and 
materials [28, 30].  
  
2.0 General Strategy 
 
Viruses and some bacteria are able to co-opt active transport systems to facilitate 
efficient transport within the cell’s cytoplasm [31-36].  For example, the infection cycle 
of Vaccinia virus requires microtubule-based transport of intracellular mature and 
extracellular enveloped forms of the virus within the cell [37, 38]. Other viruses, such as 
herpes simplex viruses, require microtubule-based transport of virions to the nucleus of 
the cell, where replication occurs, and back to the cell membrane to initiate cell-to-cell 
spread [39-42]. This ability of viruses to co-opt the cell’s active transport system raises 
an interesting question: can such intracellular transport systems be co-opted for directed 
in vivo manipulations? Specific manipulations may include collection of proteins and 
small molecules within individual cells, disrupting virus/bacterium infection cycles, 
directing the transport of effector molecules for localized stimulation, or the delivery of 
therapeutic agents to specific sites within a cell. 
The overall goal of this project was to investigate the ability to engineer kinesin-
based transport systems for in vivo applications, specifically the collection of effectors 
(e.g., transcriptional regulators) within single cells. The objectives of this work included 
(i.) engineering an analyte-selective kinesin motor protein, (ii.) characterizing the 
antigenic and catalytic properties of the analyte-selective kinesin, and (iii.) developing 
methods to harvest intact microtubule supra-structures from live cells. The following 
report summarizes the achievements of this one-year project. 
 
3.0 Engineering and characterizing analyte-selective kinesin motors 
proteins  
 
Directed in vivo manipulation of kinesin-based transport systems necessitates the 
development of engineered kinesin motor proteins with target-selective features. Thus, 
the first critical milestone of this work was engineering kinesin motor proteins with an 
integrated analyte-selective receptor. To achieve this goal, genetic engineering was 
utilized to fuse an antibody fragment, called a single chain variable fragment (scFv), to 
the tail region of conventional kinesin. The selectivity and binding affinity of the scFv for 
the target antigen, however, can be adversely affected when bound to surfaces [43] or 
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other proteins [44]. Therefore, a significant challenge of this work was the development 
of a kinesin-scFv with proper structural and functional features. 
Materials & Methods 
Genetic engineering of the kinesin-scFv 
A recombinant DNA plasmid containing a scFv specific to rabbit immunoglobulin G 
(IgG) was graciously provided by Professor Ray Mernaugh of Vanderbilt University (Fig. 
1A). Site directed mutagenesis (SDM) was used to genetically modify the scFv sequence 
Anti-Rabbit scFV plasmid
5204 bp
bla(M)
anti-Rabbit scFV (with E-tag)
E-tag
T7 promoter
M 13 ori
EcoRI (4329)
HindIII (2236)
NcoI (2322)
NdeI (4196)
NotI (3054)
NarI (4491)
PstI (2343)
PstI (2801)
Sst I (2573)
Sst I (2738)
BamHI (2849)
BamHI (3083)
BamHI (3692)
pPK113-DM Kinesin
6567 bp
CDS(bla) 1
CDS(dhk) 2
T7 promoter
BamHI (4149)
EcoRI (4903)
EcoRV (5021)
HindIII (4530)
NarI (6304)
NotI (6394)
SfiI (4671)
Sst I (5643)
XbaI (3387)
NcoI (5263)
NcoI (6103)
BglI (1269)
BglI (4671)
BglI (4737)
(A)
(B)
 
 
Figure 1. Plasmid maps of the (A) anti-rabbit immuglobulin G, single chain variable fragment, 
and (B) pPK113 Drosophila kinesin that were used to construct the fusion protein. 
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to introduce a Nar I restriction endonuclease site to facilitate the insertion of the scFv 
fragment into the kinesin expression system. Briefly, synthetic oligonucleotides 
sequences containing the mutated DNA region were synthesized by Sigma-Genosys, and 
used to generate the mutated plasmid through a variation of the polymerase chain 
reaction. The DNA lacking the mutation was then removed by restriction endonuclease 
digestion with Dpn I at 37°C for 60 min. The mutated plasmid was then transformed into 
XL-1 Blue cells (Strategene, Inc.), and characterized by restriction digests and DNA 
sequencing (Northwoods DNA, Inc).  
To construct the kinesin-scFv fusion protein, the modified scFv sequence and 
Drosophila kinesin sequence (pPK113-DM) were excised by digestion with Nar I and 
Not I restriction endonucleases (Fig. 1). This digestion removed a small portion of the 
kinesin tail from pPK113-DM, and the entire anti-rabbit IgG scFv sequence. The scFv 
and Drosophila kinesin fragments were then ligated together using the compatible, sticky 
ends, and transformed into XL-1 Blue cells. The resulting kinesin-scFv plasmid 
contained a codon frameshift that was rectified by deleting a thymidine residue at the 5’ 
end of the scFv using SDM. Finally, a 10x His tag and hard stop codon (TAA) were 
introduced to provide an easy means for protein purification and proper protein length, 
respectively. DNA sequencing of the final construct was performed by Northwoods 
DNA, Inc., and analyzed to ensure proper placement and orientation of the individual 
regions. The final kinesin-scFv plasmid was then transformed into Rosetta®2 DE3 pLysS 
cells for expression of the recombinant fusion protein. Cells were grown in Lauria-
Bertani (LB) media supplemented with ampicillin and chloramphenicol for 
approximately 4 hrs at 37ºC, induced to express the recombinant protein with isopropyl-
beta-D-thiogalactopyranoside (IPTG), and grown for an additional 4 hrs at 23ºC. Cells 
were collected by centrifugation, and lysed with BugBuster® (Novagen) to release the 
recombinant protein. The kinesin-scFv was purified by Ni-NTA affinity chromatography, 
and stored in small aliquots at -85ºC.  
Characterization of the recombinant kinesin-scFv 
The ATP hydrolytic properties of the kinesin-scFv were characterized using a 
NADH-coupled double enzyme assay [45]. The kinesin-scFv was diluted to a final 
concentration of 0.1 μM in the ATP hydrolysis assay buffer (50 mM Tris-acetate, pH 7.5, 
1 mM MgCl2, 1 mM dithiotheritol, 1 μM taxol, 1 mM MgATP, 3 mM phosphoenol-
pyruvate, 200 μM NADH, and 18 units/mL lactate dehydrogenase, and 12 units/mL 
pyruvate kinase). The addition of polymerized microtubules at a 0.5 μM concentration 
was used to stimulate ATP hydrolysis, which was monitored by measuring the 
absorbance of NADH at 340 nm on a UV-Vis spectrophotometer. ATP hydrolytic rates 
were determined by linear regression of the absorbance measurements at 340 nm as a 
function of time using SigmaStat.  
The antigenic properties of the kinesin-scFv were characterized using two modified 
enzyme-linked immunosorbent assays (ELISA). In the first assay, the efficacy of antigen 
binding to the kinesin-scFv was measured. Microtiter plates were coated with anti-kinesin 
antibodies at 37ºC for 3 hrs, washed with phosphate-buffered saline with 0.05% Tween-
20 (PBS-T) and allowed to bind the kinesin-scFv at 37ºC for 1 hr. Dilutions of an alkaline 
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phosphatase-conjugated rabbit IgG were then added and allowed to bind for 1 hr at 37ºC. 
The substrate, p-nitrophenyl phosphate (pNPP) when then added, and the absorbance at 
405 nm was measured approximately 30 min after addition of the substrate. In the second 
assay, both the antigenic binding and kinesin adhesion to microtubules was measured. 
Microtiter plates were first coated with anti-tubulin antibodies at 37ºC for 3 hrs, washed 
with PBS-T, and allowed to bind polymerized, taxol-stabilized microtubules at 37ºC for 1 
hr. The kinesin-scFv was then introduced and allowed to bind to the microtubules for 1 hr 
at 37ºC. Finally, dilutions of an alkaline phosphatase-conjugated rabbit IgG, allowed to 
bind for 1 hr at 37ºC, and the absorbance at 405 nm was measured approximately 30 min 
after addition of pNPP. One-way analysis of variance (ANOVA) was used to determine 
significant differences in the absorbance at 405 nm as a function of alkaline phosphatase-
conjugated rabbit IgG concentration.  
Results & Discussion 
The final plasmid construct, pPK113-DM-scFV, contained a 3657 bp sequence 
encoding the Drosophila kinesin-scFv fusion gene (Fig. 2A), which may be induced to 
pPK113-DM-scFv
7131 bp
CDS(bla) 1
DM Kinesin-scFv
T Deletion
T7 promoter
EcoRI (5731)
EcoRV (5849)
HindIII (5358)
MluI (783)
NarI (1)
NotI (736)
SfiI (5499)
XbaI (4215)
NdeI (4255)
BamHI (531)
BamHI (4977)
NcoI (6091)
NcoI (6931)
Sst I (255)
Sst I (420)Sst I (6471)
Kinesin-scFV
Drosophila kinesin 
motor domain
Drosophila kinesin 
helical tail domain
anti-rabbit 
scFV domain
10x His 
tag
DM-Kin scFV HisDM-Kin-Tail
(A)
(B)
 
 
Figure 2: (A) Map of the final kinesin-scFv expression plasmid. The anti-rabbit scFv was 
inserted into the pPK113 Drosophila kinesin expression plasmid, immediately downstream of 
the kinesin sequence, and terminated with a 10x His-tag. (B) Schematic diagram of the 
kinesin-scFv fusion construct showing the location of the different protein domains. 
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express recombinant protein through the T7 promotor directly upstream. DNA 
sequencing results confirmed the correct ordering of the individual domains in the gene 
sequence. This gene expressed a 1218-amino acid protein that included the kinesin motor 
domain, the kinesin coiled-coil tail, the anti-rabbit IgG scFv, and a 10x His tag (Fig. 2B). 
The purified protein had an estimated molecular weight of ~140 kDa based on SDS-
PAGE analysis (not shown), which is consistent with the predicted molecular weight of 
the primary amino acid sequence. 
The kinesin-scFv displayed microtubule-stimulated ATP hydrolysis, confirming the 
functionality of the kinesin motor domain (Fig. 3). The relative turnover rate of two 
kinesin-scFv preparations was estimated at 0.13 (R2=0.99) and 0.25 sec-1 (R2=0.99), 
similar to the estimated rate of 0.12 sec-1 for the native Drosophila kinesin (R2=0.99; Fig. 
3). These ATP hydrolytic rates, however, are significantly lower than published reports 
for Drosophila kinesin [22], and are likely attributed to denaturation of the kinesin motor 
domain during purification. While biochemical studies have shown a length-dependency 
with respect to ATP hydrolysis rates for Drosophila kinesin [46], the consistency in 
hydrolytic rates between the native kinesin and kinesin-scFv support the notion of 
preserved catalytic efficiency. In addition, retained functionality has also been reported 
for fusion proteins consisting of a human conventional kinesin and the green fluorescent 
protein [47]. Further characterization to determine the percentage of active kinesin-scFV 
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Figure 3. ATP hydrolytic activity of two preparations of the kinesin-scFv, and the native 
Drosophila kinesin. Turnover rates for the kinesin-scFV were estimated at 0.13 (-■-) and 0.25 
(-∇-) sec-1; the turnover rate of the native kinesin control was estimated at 0.12 sec-1 (-●-). 
Turnover rates were determined using linear regression analysis. 
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and the specific activity (i.e., turnover rate of active motors) is necessary to further 
understand the effects of adding the scFv to the kinesin tail. 
The kinesin-scFv also retained the antigen binding and selectivity intrinsic to the anti-
rabbit scFv. In both modified ELISAs, a dose-response was observed across the range of 
conjugated rabbit IgG concentrations (Fig. 4). Significant differences between control 
and dilutions of the rabbit IgG conjugated were observed by ANOVA (P < 0.001). In the 
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Figure 4: Standard curves for the detection of rabbit immunoglobulin G (IgG)-alkaline 
phosphatase by the kinesin-scFV fusion protein using two modified ELISAs. In the first assay, 
kinesin-scFv was bound to microtiter plates using anti-kinesin antibodies (A).  In the second 
assay, kinesin-scFv was bound to microtubules present in the microtiter plate wells (B). 
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first ELISA, binding of rabbit IgG was detectable at levels as low as 10 ng/mL (Fig. 4A; 
P < 0.001), confirming preserved scFv functionality. However, the ability of the kinesin-
scFv to bind microtubule filaments was not tested in this assay. The functionality of both 
the kinesin and scFv were evaluated in the second ELISA-based procedure. Binding of 
kinesin-scFv to the microtiter plates was facilitated through microtubules that had been 
bound to the surface of the plate though anti-tubulin antibodies. Binding of rabbit IgG by 
the kinesin-scFv was detected at concentrations of 120 ng/mL and greater (Fig. 4B; P < 
0.001). Together these assays demonstrate the preserved antigenic selectivity of the scFv 
as well as the microtubule-binding affinity of the kinesin motor domain. 
The rationale for introducing the anti-rabbit IgG scFv was to create a generalized 
platform for functionalizing kinesin with analyte-selective receptors. Polyclonal antisera 
is produced in rabbits, and widely applied in immunological assays for detection of 
analytes. The affinity of the anti-rabbit IgG scFv for the constant region of rabbit IgG 
enables the attachment of antibodies for a wide array of cellular analytes. Thus, 
construction of the kinesin-scFv specific against rabbit IgG enables the rapid construction 
of a library of analyte-selective kinesins through the simple binding of a target-selective 
IgG raised in rabbits. 
 
4.0 Harvesting intact microtubule networks 
 
Kinesin motor proteins have been shown to transport a wide range of micro- and 
nano-scale particles along microtubule filaments bound to synthetic surfaces [48, 49]. 
While significant efforts have been made on fabricating microtubule networks in artificial 
systems [50-52], only sparse two-dimensional arrays have been achieved to date, and do 
not mimic the natural, three-dimensional architectures found in living systems. It was 
hypothesized that the existing microtubule network within a cell could be harvested, and 
serve as a nanoscale scaffold for evaluating and exploiting three-dimensional in vitro 
transport by kinesin motor proteins.  
Materials & Methods 
Harvesting microtubules from HeLa and B35 cells 
Human liver (HeLa) and rat neuronal (B35) cell lines were obtained from the 
American Type Culture Collection (ATTC), and cultivated at 37ºC in Dulbecco's 
modified Eagle's medium with 10% fetal bovine serum (5% CO2). Cell cultures were 
grown to 80-100% confluency on glass coverslips in 6-well culture plates. Coverslips 
were gently washed with phosphate buffered saline (1x PBS) warmed to room 
temperature. For the methanol-based fixation method, coverslips were incubated with 
extraction buffer (BRB80 + 4 mM EGTA + 0.5% Taxol + ATP [1mM-100mM]) for 30 
sec, fixed with cold methanol for 3 min, and subsequently air dried. For glutaraldehyde 
fixation, coverslips were incubated in microtubule stabilizing buffer (BRB80 + 4 mM 
EGTA + 0.5% Taxol) for 30 sec, fixed with 0.5% glutaraldehyde for 10 min at 25ºC, 
washed with fresh buffer, and air dried. 
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Microtubule networks were fluorescently stained using either anti-tubulin antibodies 
or BODIPY® FL paclitaxel (Invitrogen Corp). In the first method, coverslips were 
rehydrated with Tris-buffered saline (1x TBS) with 0.1% Triton X-100, and incubated 
with a 1:100 dilution of mouse anti-αβ tubulin (diluted in TBS + 0.1% Triton X-100 + 
2% BSA) for 15-120 min in the dark at 25ºC. Coverslips were then washed three times 
with TBS, and a 1:100 dilution of Alexa Fluor® 488 goat anti-mouse antibody (diluted in 
TBS + 0.1% Triton X-100 + 20 mg/mL BSA) was added for 15-60 min in the dark at 
25ºC. Stained microtubule networks were washed three times with TBS, and mounted on 
glass slides using Cytoseal (Richard Allan Scientific). For the second method, the dried 
coverslips were rehydrated with a 10 μM solution of BODIPY® FL paclitaxel in BRB80, 
and incubated for 15 min in the dark at 25ºC. Excess solution was wicked from the 
coverslip using filter paper, and coverslips were allowed to air dry. The dried coverslip 
were then used to create a flow cell in which a 10 μM solution of BODIPY® FL 
paclitaxel in BRB80 was infused in order to maintain fluorescence of the microtubule 
networks. 
In vitro motility assays on microtubule networks 
The ability of the harvested microtubule networks to support kinesin-based transport 
was evaluated using a bead-based motility assay [48, 49]. Microtubule networks were 
incubated with 10 μM solution of BODIPY® FL paclitaxel for 15 min at 25ºC. Coverslips 
were then allowed to dry, and used to construct flow cells. Silica (200 and 500 nm 
diameter) and fluorescent, carboxylate-modified polystyrene (200 nm diameter) spheres 
were washed with BRB80 to remove excess surfactant, and coated with a 4 mg/mL 
solution of casein. Suspensions were sonicated for 5 min, and incubated at 4ºC for 1-2 hrs 
with gentle shaking. Casein-coated spheres were then functionalized with a five-fold 
monolayer coverage of Drosophila kinesin at 4ºC for 1 hr. Nanocrystal quantum dots 
(e.g., carboxyl Qdot®525, Invitrogen, Corp) were also functionalized with kinesin using 
this protocol. Kinesin-coated spheres and quantum dots were infused into flow cells, and 
movement was evaluated by epifluorescence microscopy and capturing time-lapse 
images using a CCD camera. 
Results & Discussion 
Epifluorescence microscopic evaluation of the fixed microtubule networks 
demonstrated the ability to harvest intact microtubule networks from HeLa cells using 
both glutaraldehyde and methanol fixation methods (Fig. 5). Similar results were 
obtained for B35 rat neuronal cells (not shown). While both methods successfully 
isolated microtubule networks, methanol fixation was superior based on the high 
fluorescence background observed with glutaraldehyde (Fig. 5C). Quenching reagents 
may be used in the future to reduce this background fluorescence, but require additional, 
time-intensive processing steps. Together these methodologies represent a key enabling 
technology for this project as well as a range of nanotechnological applications. More 
specifically, the ability to transport nanoscale cargo in three-dimensions greatly enhances 
the application of kinesin transport systems that are currently limited to planar systems 
[49-51, 53]. These microtubule networks can be used to study the kinetic rates of 
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transport and analyte capture, on which models can be developed to predict functionality 
in live cells. In addition, the cell’s microtubule architecture can be applied to hybrid 
nanoscale system as a three-dimensional transport network that may be used to synthesize 
structured materials.  
Attachment of kinesin-coated quantum dots, and silica and polymer spheres to 
microtubules was observed by fluorescence microscopy (Fig. 6); movement, however, 
was not demonstrated for microtubule networks prepared by either fixation method. 
Control experiments demonstrated the ability of kinesin-coated silica spheres to move 
(A)
(B)
(C)
 
 
Figure 5: Fluorescence micrographs of intact microtubule networks isolated from HeLa cells 
using 0.5% methanol (A), 1% methanol (B), and 0.5% glutaraldehyde (C). Microtubules were 
stained with taxol.  
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along polymerized microtubules, confirming the integrity of the kinesin and assay 
components. Kinesin-based transport of quantum dots was not verified in control 
experiments. A number of factors could have potentially limited kinesin function, 
including the presence of microtubule-associated proteins, excessive crosslinking of 
tubulin molecules, and increased stiffness of the microtubule filaments. Glutaraldehyde 
crosslinking of microtubules has been shown to adversely affect kinesin-based transport 
that is related to the reaction time and crosslinker concentration [54, 55]. However, the 
glutaraldehyde concentration used for harvesting the microtubule networks was below the 
critical threshold shown to inhibit kinesin motility. The presence of microtubule 
associated proteins (MAPs) may also have affected kinesin movement on harvest 
microtubule networks. Recently, kinesin-based transport of nanocrystal quantum dots 
was demonstrated [56], which suggests that modified kinesin constructs can successfully 
move in vivo along MAP-coated microtubules. A reduction in the in vitro motility 
(A)
(B)
 
 
Figure 6: Fluorescence photomicrograph showing the attachment of kinesin-coated silica 
spheres (A) and quantum dots (B) to fluorescently labeled microtubule networks harvested 
from HeLa cells. 
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velocity, but not processivity of the kinesin-coated quantum dots, was demonstrated 
along microtubule fibers that had been treated with non-functional kinesin mutants 
demonstrated [57]. Thus, steric interference due to MAPs or indigenous kinesin proteins 
may have affected the transport of kinesin-coated spheres and quantum dots on the 
harvested microtubule networks. New methods of functionalizing spheres and quantum 
dots using biotinylated kinesin [53, 56, 57] are currently being evaluated with respect to 
facilitating transport. Further investigation in the nature of the observed inhibition is 
fundamental to the future application of these microtubule networks for 
nanotechnological applications. 
 
5.0 Conclusions 
 
While significant efforts have been placed on applying kinesin-based transport system 
for nanotechnological application [28-30], this project explored nanoscale engineering of 
kinesin motor proteins as a means of manipulating active transport within living cells. To 
this end, a chimeric, fusion protein consisting of kinesin and an antibody fragment (i.e., 
scFv) were successfully produced through a bacterial expression system. The kinesin-
scFv retained both catalytic and antigenic functionality, enabling selective capture and 
transport of target antigens. Successful isolation of intact microtubule networks from two 
distinct cell types was also demonstrated, and will provide a platform for inferring the 
ability of kinesin-scFv to function in vivo. Such networks may also serve as a three-
dimensional scaffold for evaluating and exploiting kinesin-based transport for 
nanotechnological applications. 
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